Oslo-based investment group Bluefront Equity announced Tuesday it reached an agreement to acquire a "significant stake" in aquaculture advisory and engineering firm AquaBioTech Group.
Malta-based AquaBioTech specializes in aquaculture, fisheries and marine consulting and research, and the development of turnkey Recirculating Aquaculture Systems (RAS) for commercial and research use, including hatcheries and grow-out facilities for several species including salmon and shrimp.
In addition, the company serves as a contract research organization for the European Union on more than 50 RAS projects.
